Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at SEK 962.6B, ahead of Eli Lilly (SEK 666.1B) and Merck & Co (SEK 664.4B). Figures as of 20 Nov 2026, 10:55 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonSEK 962.6B
- Median
- SEK 32.7B
- Combined market value
- SEK 50.71T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SEK 962.6B | SEK 6.57T | SEK 2,729.95 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | SEK 666.1B | SEK 12.3T | SEK 13,807.35 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 664.4B | SEK 3.35T | SEK 1,357.21 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | SEK 639.5B | SEK 1.6T | SEK 281.44 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | SEK 625B | SEK 5.12T | SEK 2,897.55 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SEK 600.3B | SEK 2.78T | SEK 1,792.55 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | SEK 557.3B | SEK 2.92T | SEK 1,545.35 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | SEK 494.6B | SEK 1.13T | SEK 470.70 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | SEK 492.5B | SEK 1.22T | SEK 596.19 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | SEK 468.7B | SEK 1.75T | SEK 397.22 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | SEK 453B | SEK 1.84T | SEK 1,061.47 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | SEK 443.1B | SEK 979.5B | SEK 488.68 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | SEK 288.4B | SEK 699B | SEK 218.79 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 176.4B | SEK 459.6B | SEK 393.85 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SEK 146.6B | SEK 976.1B | SEK 9,435.79 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | SEK 146.1B | SEK 232.9B | SEK 203.16 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SEK 122.6B | SEK 1.35T | SEK 5,320.72 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | SEK 96.7B | SEK 335.5B | SEK 825.61 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | SEK 85.3B | SEK 57B | SEK 83.80 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | SEK 54.6B | SEK 466.6B | SEK 4,084.61 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | SEK 48.2B | SEK 134.3B | SEK 268.66 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 43.6B | SEK 155.1B | SEK 2,416.33 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | SEK 38B | SEK 323.6B | SEK 524.76 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SEK 38B | SEK 202.3B | SEK 1,510.60 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 36.5B | SEK 126.3B | SEK 151.55 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SEK 32.9B | SEK 121.6B | SEK 627.66 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | SEK 32.5B | SEK 243.3B | SEK 5,713.55 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | SEK 30.8B | SEK 76.2B | SEK 218.59 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | SEK 24.3B | SEK 397.9B | SEK 692.04 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SEK 17.7B | SEK 49.8B | SEK 596.03 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | SEK 15.1B | SEK 79.3B | SEK 471.92 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | SEK 10.5B | SEK 31.9B | SEK 164.53 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 9.8B | SEK 94.2B | SEK 4,054.36 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SEK 9.6B | SEK 46.3B | SEK 278.17 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 8.5B | SEK 63.1B | SEK 446.07 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | SEK 8.2B | SEK 171.6B | SEK 2,615.70 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | SEK 7.8B | SEK 72.7B | SEK 664.04 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 6.9B | SEK 75.1B | SEK 955.85 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SEK 6.5B | SEK 72.9B | SEK 1,386.54 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | SEK 6.3B | SEK 100.2B | SEK 663.02 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | SEK 6.2B | SEK 323.9B | SEK 1,476.26 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.3B | SEK 63.7B | SEK 976.03 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | SEK 5.1B | SEK 155.6B | SEK 798.94 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 47.4B | SEK 493.59 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | SEK 2.7B | SEK 58.7B | SEK 2,932.29 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.9B | SEK 82.8B | SEK 1,193.60 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | SEK 899.7M | SEK 73.3B | SEK 525.88 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | SEK 470.2M | SEK 82.7B | SEK 1,267.38 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | SEK 84.4M | SEK 288.5B | SEK 398.14 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | SEK 20.8M | SEK 48.8B | SEK 866.89 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | SEK 0 | SEK 94.8B | SEK 997.70 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | SEK 0 | SEK 88.8B | SEK 3,177.15 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.2192 SEK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (SEK 962.6B), Eli Lilly (SEK 666.1B) and Merck & Co (SEK 664.4B) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 10:55 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of SEK 50.71T as of 20 Nov 2026, 10:55 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.